![](/img/cover-not-exists.png)
Phase I Trial of Gemcitabine, Administered as a Standard and Constant Dose-Rate Infusion, in Combination With Paclitaxel in Patients With Advanced Solid Tumors (LOA-2)
Rinaldi, David A., Lormand, Nancy A., Brierre, Joseph E., Cole, James L., Stagg, M. Patrick, Fontenot, M. Felicia, Buller, Eric J., Rainey, John M.Volume:
25
Language:
english
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/00000421-200210000-00021
Date:
October, 2002
File:
PDF, 174 KB
english, 2002